Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000477

Chief Executive Officer bought 100,000 shares at $2.50 ($250,000)

From the SEC's structured data for this filing

Trades in this filing

COLA MICHAEL F · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-06-09 Purchase : show line 1 in the form +100,000 $2.50 $250,000 175,746 D
Open-market purchases · 100,000 sh · avg $2.50 · $250,000
Loading xslF345X03/edgar.xml…